Orphan drug pricing may warrant a competition law investigation
BMJ
.
2010 Nov 16:341:c6471.
doi: 10.1136/bmj.c6471.
Authors
Jonathan C P Roos
1
,
Hanna I Hyry
,
Timothy M Cox
Affiliation
1
Department of Medicine, University of Cambridge, Cambridge CB2 2QQ, UK.
PMID:
21081598
DOI:
10.1136/bmj.c6471
No abstract available
MeSH terms
Drug Costs
Economic Competition / legislation & jurisprudence*
European Union
Orphan Drug Production / economics*
Orphan Drug Production / legislation & jurisprudence